Continuum Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
4,929
+355
| +8% | +$39.4K | 0.07% | 251 |
|
|
2025
Q1 | $513K | Sell |
4,574
-47
| -1% | -$5.27K | 0.07% | 231 |
|
|
2024
Q4 | $427K | Sell |
4,621
-13
| -0.3% | -$1.2K | 0.05% | 265 |
|
|
2024
Q3 | $427K | Sell |
4,634
-21
| -0.5% | -$1.93K | 0.05% | 268 |
|
|
2024
Q2 | $319K | Sell |
4,655
-442
| -9% | -$30.3K | 0.05% | 294 |
|
|
2024
Q1 | $329K | Sell |
5,097
-8,894
| -64% | -$574K | 0.05% | 289 |
|
|
2023
Q4 | $1.13M | Buy |
13,991
+539
| +4% | +$43.7K | 0.16% | 156 |
|
|
2023
Q3 | $1.01M | Sell |
13,452
-125
| -0.9% | -$9.37K | 0.16% | 162 |
|
|
2023
Q2 | $1.05M | Sell |
13,577
-5,740
| -30% | -$442K | 0.17% | 157 |
|
|
2023
Q1 | $1.6M | Sell |
19,317
-781
| -4% | -$64.8K | 0.27% | 105 |
|
|
2022
Q4 | $1.73M | Buy |
20,098
+764
| +4% | +$65.6K | 0.31% | 92 |
|
|
2022
Q3 | $1.19M | Buy |
19,334
+666
| +4% | +$41.1K | 0.21% | 128 |
|
|
2022
Q2 | $1.15M | Buy |
18,668
+4,187
| +29% | +$259K | 0.21% | 131 |
|
|
2022
Q1 | $859K | Buy |
+14,481
| New | +$859K | 0.16% | 155 |
|
|
2021
Q3 | – | Sell |
-4,135
| Closed | -$285K | – | 299 |
|
|
2021
Q2 | $285K | Sell |
4,135
-169
| -4% | -$11.6K | 0.09% | 217 |
|
|
2021
Q1 | $283K | Sell |
4,304
-739
| -15% | -$48.6K | 0.12% | 141 |
|
|
2020
Q4 | $294K | Hold |
5,043
| – | – | 0.13% | 121 |
|
|
2020
Q3 | $319K | Sell |
5,043
-1,474
| -23% | -$93.2K | 0.17% | 113 |
|
|
2020
Q2 | $496K | Buy |
6,517
+1,597
| +32% | +$122K | 0.31% | 73 |
|
|
2020
Q1 | $357K | Buy |
+4,920
| New | +$357K | 0.24% | 90 |
|